Ms. Huss has served as a director of the Company since March 2022. She has served as the Chief Executive Officer of Pagonia Medical, Inc. (“Pagonia”), a private company focused on creating a novel non-invasive device for the preservation of tissue following a heart attack, stroke, traumatic brain injury and other medical conditions since January 2021. From September 2013 until January 2021, she served as President and Chief Executive Officer of Qool Therapeutics, Inc. (“Qool”), formerly Thermocure, Inc., a company focused on temperature management therapies that underwent an assignment for the benefit of creditors under California law in November 2020 as a result of the COVID-19 pandemic. Prior to joining Qool, Ms. Huss was President and Chief Executive Officer at a start-up medical device company, Vibrynt, Inc., and held multiple senior level leadership positions at Guidant Corporation, including, President, Endovascular Solutions, and Vice President, Global Marketing, Vascular Intervention, and Vice President of the Stent Business Unit. Ms. Huss currently serves on the board of directors of Pagonia, Madorra Inc., a privately-held medical device company developing solutions to improve quality of life after menopause (executive chair of the board), Accuray Incorporated, a publicly-held radiation oncology company (compensation chair), Coala-Life Group AB, a Swedish public medical device company developing heart monitors, and Ancora Heart, Inc., a privatelyheld medical device company developing heart failure treatments. Her prior public company board experience includes Artes Medical, Inc., Wright Medical Group N.V. and Dade Behring Holdings, Inc. Ms. Huss holds a B.S. in metallurgical engineering from the University of Illinois and a M.S. in technology management from Pepperdine University.
What is Beverly A. Huss' net worth?
The estimated net worth of Beverly A. Huss is at least $65.96 thousand as of April 23rd, 2025. Huss owns 92,639 shares of IRIDEX stock worth more than $65,959 as of October 6th. This net worth estimate does not reflect any other assets that Huss may own. Learn More about Beverly A. Huss' net worth.
How do I contact Beverly A. Huss?
Has Beverly A. Huss been buying or selling shares of IRIDEX?
Beverly A. Huss has not been actively trading shares of IRIDEX during the past quarter. Most recently, on Wednesday, April 23rd, Beverly A. Huss bought 25,900 shares of IRIDEX stock. The stock was acquired at an average cost of $1.22 per share, with a total value of $31,598.00. Following the completion of the transaction, the director now directly owns 92,639 shares of the company's stock, valued at $113,019.58. Learn More on Beverly A. Huss' trading history.
Who are IRIDEX's active insiders?
Are insiders buying or selling shares of IRIDEX?
In the last year, IRIDEX insiders bought shares 2 times. They purchased a total of 50,000 shares worth more than $48,500.00. The most recent insider tranaction occured on November, 17th when Director William M Moore bought 21,843 shares worth more than $21,187.71. Insiders at IRIDEX own 8.6% of the company.
Learn More about insider trades at IRIDEX. Information on this page was last updated on 11/17/2025.
